Showing results (71-80 of 482) with videos related to
Sort By:
Pageof 49
Genome Medicine|February 26, 2011
Tackling Ebola: new insights into prophylactic and therapeutic intervention strategiesEmmie de Wit, Heinz Feldmann, Vincent J MunsterVirus Research|August 23, 2002
Molecular characterization of an isolate from the 1989/90 epizootic of Ebola virus Reston among macaques imported into the United StatesAllison Groseth, Ute Ströher, Steven Theriault, et al.The Journal of Infectious Diseases|December 6, 2007
Blockage of filoviral glycoprotein processing by use of a protein-based inhibitorUte Ströher, Laura Willihnganz, François Jean, et al.The Journal of Infectious Diseases|June 12, 2015
Considerations in the Use of Nonhuman Primate Models of Ebola Virus and Marburg Virus InfectionThomas W Geisbert, James E Strong, Heinz FeldmannTrends in Molecular Medicine|April 18, 2006
Ebola virus: unravelling pathogenesis to combat a deadly diseaseThomas Hoenen, Allison Groseth, Darryl Falzarano, et al.Plos Pathogens|September 16, 2021
The Ebola virus soluble glycoprotein contributes to viral pathogenesis by activating the MAP kinase signaling pathwayWakako Furuyama, Kyle Shifflett, Heinz Feldmann, et al.Emerging Microbes & Infections|February 13, 2025
Longitudinal seroprevalence of Crimean-Congo hemorrhagic fever virus in Southern UgandaEvan A Mihalakakos, Victor Ssempijja, Ruy M Ribeiro, et al.Nature Communications|October 25, 2024
Antibodies targeting the Crimean-Congo Hemorrhagic Fever Virus nucleoprotein protect via TRIM21Shanna S Leventhal, Thomas Bisom, Dean Clift, et al.Journal of Virology|March 22, 2013
A tyrosine-to-histidine switch at position 18 of the Ross River virus E2 glycoprotein is a determinant of virus fitness in disparate hostsHenri J Jupille, Melisa Medina-Rivera, David W Hawman, et al.Microorganisms|April 30, 2021
Lassa Virus Treatment OptionsFrederick Hansen, Michael A Jarvis, Heinz Feldmann, et al.Pageof 49